Laura Lee Sandler serves as Chief Operating Officer at Oruka Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Laura Lee Sandler has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 23, 2026 involved receiving (via award) 130,000 shares valued at $0.
Laura Lee Sandler currently holds 130,000 shares of Oruka Therapeutics, Inc. (ORKA), valued at approximately $0. This represents their equity stake as Chief Operating Officer.
Based on SEC Form 4 filings, Laura Lee Sandler has been a net neutral trader of ORKA stock. They have purchased $0 and sold $0 worth of shares.
Laura Lee Sandler's most recent insider trade was on Jan 23, 2026, when they sold 130,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |